An Act authorizing a 90-day supply of medically necessary testosterone therapy medication
This bill permits pharmacies to provide a 90-day supply of medically necessary testosterone therapy medication to patients. It aims to ensure that individuals who require this medication have adequate access without needing to refill prescriptions frequently.
Do you support it?
Want to know if it passes?
We'll email you when H2447 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on H2447.
You're tracking H2447
We'll email you the moment it moves.
H2447 — An Act authorizing a 90-day supply of medically necessary testosterone therapy medication
No card. One bill, free forever — alerts when it moves.
-
1Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 194th General Court. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
In plain language
The bill allows a 90-day supply of testosterone therapy medication.
This bill permits pharmacies to provide a 90-day supply of medically necessary testosterone therapy medication to patients. It aims to ensure that individuals who require this medication have adequate access without needing to refill prescriptions frequently.
What this means for you
- Patients: This means you can receive a larger supply of necessary testosterone therapy medication at once.
Summary
An Act authorizing a 90-day supply of medically necessary testosterone therapy medication
Bill Text
- Full text Current
AI-generated reading aid from the bill's amendatory text — verify against the official bill.
The bill allows prescriptions for medically necessary testosterone therapy to be filled for a 90-day supply upon a single filling.
-
Chapter 94C, Section 23(d)
and provided, further, that a prescription for medically necessary testosterone therapy medication may be filled for up to a 90-day supply upon a single filling, and medical necessity shall be determined by the treating clinician in consultation with the patient and specifically noted with the written prescription and in the patient’s medical record.
This addition enables a longer supply of testosterone therapy medications in a single prescription, based on medical necessity.
Sponsors
- Natalie M. Higgins · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 203 not signed on
Sponsors (1)
- Natalie M. Higgins Democrat
Co-sponsors (0)
None.
Not signed on (203)
203 members have not signed on to this bill.
Show all 203 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does H2447 do?
- An Act authorizing a 90-day supply of medically necessary testosterone therapy medication
- Who sponsors H2447?
- H2447 is sponsored by Natalie M. Higgins (Democrat).
- What is the current status of H2447?
- This bill died with 194th General Court. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track H2447?
- Track H2447 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on H2447
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of H2447
Last checked for changes 4 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →